leadf
logo-loader
AIM:AMYT NASDAQ:AMYT

Amryt Pharma PLC

Receive alerts
Market:
AIM
Market Cap:
£323.83 m
Price
199.00 GBX
Change
2.05%
52 weeks high
250.00
52 weeks low
80.00

In brief

Amryt Pharma is a commercial stage pharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of people with rare and orphan diseases.

Snapshot

  • A revenue-generating orphan drugs company
  • Completed a transformational deal
  • Expected to be a high growth business